Windlas Biotech Ltd IPO

The Windlas Biotech Ltd's ₹402 Cr IPO will open for subscription from 4th August, 2021.

The Windlas Biotech Ltd's IPO market lot size is of 30 shares. A retail-individual investor can apply for up to 14 lots (total 420 shares at ₹193,200).

The issue will close on 6th August, 2021.

 Windlas Biotech IPO Details

 Windlas IPO Calendar

The company incorporated in 2001, Windlas Biotech Ltd is one of the leading companies in the pharmaceutical formulations contract development and manufacturing organizations (CDMO) segment in India. The company offers a range of CDMO services from product discovery to product development, licensing, and commercial manufacturing of generic products including complex generics.

The firm further sells its own branded products in the trade generics and OTC markets. Currently, the focus of the company is to launch complex generic products in the chronic therapeutic category related to lifestyle-related disorders. The business operates in 3 verticals; 1. CDMO Products and services, 2. Domestic trade generics and Over-the-counter (OTC) market (nutraceutical and health supplement products), and 3. Export.

Its manufacturing facilities are located at Dehradun with an installed operating capacity of 7,063.83 million tablets/ capsules, 54.46 million pouch/ sachet, and 61.08 million liquid bottles.